INBIOS INTERNATIONAL INC

INBIOS INTERNATIONAL INC specializes in the design, development, and manufacturing of in-vitro diagnostic substances and rapid point-of-care test kits, with deep technical expertise in immunoassay platforms, serological detection, and self-collected sample technologies. The company has demonstrated consistent capability in creating clinical diagnostic solutions for infectious disease and biomarker detection, including ELISA-based kits and finger-stick blood assays for prostate-specific antigen. Their work spans research and development in biotechnology, particularly in translating laboratory innovations into FDA-cleared or authorized consumer and clinical diagnostic products. A key differentiator is their ability to bridge biotech R&D with scalable manufacturing of diagnostic reagents and test systems, ensuring regulatory readiness and field deployability for both public health and defense applications. The contractor maintains a strong, long-standing relationship with the Department of Health and Human Services, delivering diagnostic test systems for public health emergencies and routine screening, including OTC COVID-19 tests and infectious disease detection kits. They also support the Department of Defense with specialized diagnostic tools for visceral disease detection and military health readiness, indicating a focus on field-deployable, ruggedized testing platforms for operational environments. INBIOS operates primarily within NAICS 325413 (in-vitro diagnostic manufacturing) and 541711/541714 (biotechnology R&D), positioning itself at the intersection of clinical diagnostics and applied biotech innovation. Their market focus is on rapid, accurate, and accessible diagnostic solutions for infectious diseases, biomarker monitoring, and point-of-care applications in both civilian and military health systems. As a small business structured as a 2L entity based in Seattle, WA, INBIOS INTERNATIONAL INC is a nimble, technically focused contractor without federal certifications, relying on proven R&D and manufacturing execution to secure mission-critical contracts. Their geographic presence and technical agility make them a trusted partner for agencies requiring rapid diagnostic innovation and scalable production.